In cope, hASCs administered IP, not IV, in STZ-diabetes dramatically increased the amount of replicating islet cells, islet area and number, the level of epidermal growth factor (EGF) gene, and Th1/Th2 response balance, which in turn improved both glycemic control and the animals’ body weight. The gene discussed is EGF; the disease is diabetes mellitus.